Supply Chain

The network now includes 30 pharmacies, who will help tackle accessibility.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.

The latest accreditation further establishes the company’s reputation in the pharma and healthcare logistics space.

Radio frequency identification (RFID) not only helps hospitals boost their medication safety standards, it also allows clinicians to continue to provide quality patient care.

Per the US strategic partnership agreement, the adalimumab high-concentration interchangeable biosimilar will be distributed under the Quallent Pharmaceuticals private label.

The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.

The CRO earned a Bronze rating for criteria based on environmental, social, and ethical performance.

IATA data points to a fourth consecutive month of double-digit, year-on-year growth.

The CDMO’s boost in production will be centered around pharmaceutical products.

There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?

The move features the launch of an innovation center revolving around cell and gene services.

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

A panel uncovers the value in meeting carbon-neutral goals by 2030.

Masterclass session addresses looking beyond a dashboard by added capabilities with added value.

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

Wattala warehouse is expected to offer both export consolidation and 3PL services for trade routes that link Africa, Asia, and Europe.

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.

The program recognizes organizations that prioritize the highest standards of care when it comes to the handling and transportation of goods in the healthcare space.

The program intends to address pharmacy deserts, which are predominantly found in underserved communities.

Year-on-year growth in demand is strong, according to the IATA.

Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.

Analysis determines the suggested value of medications for diabetes if they were closer to production costs.

Syneos Health's Kim Plesnarski uncovers the key issues that customers are currently trying to address, including the retail shift from small-molecule products to biologics.

A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.